Utilizing nanopore sequencing technology for the rapid and comprehensive characterization of eleven HLA loci; addressing the need for deceased donor expedited HLA typing

被引:41
|
作者
Mosbruger, Timothy L. [1 ]
Dinou, Amalia [1 ]
Duke, Jamie L. [1 ]
Ferriola, Deborah [1 ]
Mehler, Hilary [1 ]
Pagkrati, Ioanna [1 ]
Damianos, Georgios [1 ]
Mbunwe, Eric [2 ,4 ]
Sarmady, Mahdi [1 ,3 ]
Lyratzakis, Ioannis [1 ]
Tishkoff, Sarah A. [2 ]
Dinh, Anh [1 ,3 ]
Monos, Dimitri S. [1 ,3 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[4] Univ Massachusetts Lowell, Dept Chem, Lowell, MA USA
关键词
Human Leukocyte Antigens; NGS; Oxford Nanopore sequencing; Transplantation; HLA genotyping; HIGH-RESOLUTION; MISMATCH;
D O I
10.1016/j.humimm.2020.06.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The comprehensive characterization of human leukocyte antigen (HLA) genomic sequences remains a challenging problem. Despite the significant advantages of next-generation sequencing (NGS) in the field of Immunogenetics, there has yet to be a single solution for unambiguous, accurate, simple, cost-effective, and timely genotyping necessary for all clinical applications. This report demonstrates the benefits of nanopore sequencing introduced by Oxford Nanopore Technologies (ONT) for HLA genotyping. Samples (n = 120) previously characterized at high-resolution three-field (HR-3F) for 11 loci were assessed using ONT sequencing paired to a single-plex PCR protocol (Holotype) and to two multiplex protocols OmniType (Omixon) and NGSgo (R)-MX6-1 (GenDx). The results demonstrate the potential of nanopore sequencing for delivering accurate HR-3F typing with a simple, rapid, and cost-effective protocol. The protocol is applicable to time-sensitive applications, such as deceased donor typings, enabling better assessments of compatibility and epitope analysis. The technology also allows significantly shorter turnaround time for multiple samples at a lower cost. Overall, the nanopore technology appears to offer a significant advancement over current next-generation sequencing platforms as a single solution for all HLA genotyping needs.
引用
收藏
页码:413 / 422
页数:10
相关论文
共 21 条